Yadi Geng

870 total citations
20 papers, 718 citations indexed

About

Yadi Geng is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Yadi Geng has authored 20 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Yadi Geng's work include Autophagy in Disease and Therapy (5 papers), Phytochemical compounds biological activities (5 papers) and Plant biochemistry and biosynthesis (4 papers). Yadi Geng is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Phytochemical compounds biological activities (5 papers) and Plant biochemistry and biosynthesis (4 papers). Yadi Geng collaborates with scholars based in China and United States. Yadi Geng's co-authors include Chao Zhang, Lei Yang, Ling‐Yi Kong, Yuan‐Zheng Xia, Yamin Shi, Zhaolin Chen, Chao Guo, Aizong Shen, Lingyi Kong and Xiaojun Feng and has published in prestigious journals such as Small, Biochemical Pharmacology and RSC Advances.

In The Last Decade

Yadi Geng

20 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yadi Geng China 15 474 186 93 90 83 20 718
Xuhui Tong China 9 650 1.4× 238 1.3× 87 0.9× 90 1.0× 74 0.9× 16 1.1k
Mohammad Jalili‐Nik Iran 18 338 0.7× 107 0.6× 112 1.2× 55 0.6× 69 0.8× 52 862
Ying Hou China 17 441 0.9× 130 0.7× 43 0.5× 64 0.7× 47 0.6× 30 735
Shulong Jiang China 19 450 0.9× 216 1.2× 78 0.8× 64 0.7× 56 0.7× 55 880
Saiprasad Gowrikumar United States 15 331 0.7× 99 0.5× 48 0.5× 75 0.8× 45 0.5× 20 736
Yuan Gu China 17 487 1.0× 121 0.7× 81 0.9× 35 0.4× 55 0.7× 58 886
Nina Xue China 18 508 1.1× 94 0.5× 42 0.5× 50 0.6× 52 0.6× 46 896
Anqi Zeng China 17 435 0.9× 136 0.7× 50 0.5× 54 0.6× 67 0.8× 45 858
Jialin Sun China 14 366 0.8× 130 0.7× 66 0.7× 37 0.4× 36 0.4× 46 631

Countries citing papers authored by Yadi Geng

Since Specialization
Citations

This map shows the geographic impact of Yadi Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yadi Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yadi Geng more than expected).

Fields of papers citing papers by Yadi Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yadi Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yadi Geng. The network helps show where Yadi Geng may publish in the future.

Co-authorship network of co-authors of Yadi Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Yadi Geng. A scholar is included among the top collaborators of Yadi Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yadi Geng. Yadi Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geng, Yadi, et al.. (2023). Xanthatin suppresses pancreatic cancer cell growth via the ROS/RBL1 signaling pathway: In vitro and in vivo insights. Phytomedicine. 119. 155004–155004. 11 indexed citations
2.
Liu, Yunxiao, Xinge Zhang, Wei Cao, et al.. (2023). Xanthatin induce DDP‐resistance lung cancer cells apoptosis through regulation of GLUT1 mediated ROS accumulation. Drug Development Research. 84(6). 1266–1278. 6 indexed citations
3.
Geng, Yadi, Yunxiao Liu, Xuan Nie, et al.. (2023). Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO2 nanoparticles for efficient cancer treatment. Nanoscale Advances. 5(12). 3336–3347. 6 indexed citations
4.
Liu, Ping, et al.. (2022). Xanthatin inhibits non‐small cell lung cancer proliferation by breaking the redox balance. Drug Development Research. 83(5). 1176–1189. 14 indexed citations
5.
Li, Lingli, Ping Liu, Yunxiao Liu, et al.. (2021). Xanthatin inhibits human colon cancer cells progression via mTOR signaling mediated energy metabolism alteration. Drug Development Research. 83(1). 119–130. 19 indexed citations
6.
Shen, Aizong, Lei Zhang, Yadi Geng, et al.. (2021). TMT-Based Quantitative Proteomic Analysis Identified Proteins and Signaling PathwaysInvolved in the Response to Xanthatin Treatment in Human HT-29 Colon CancerCells. Anti-Cancer Agents in Medicinal Chemistry. 22(5). 887–896. 5 indexed citations
7.
Chen, Zhaolin, Tingting Pan, Yadi Geng, et al.. (2020). The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway. Molecular Therapy — Nucleic Acids. 19. 1434–1448. 113 indexed citations
8.
Feng, Xiaojun, Yanan Wang, Suowen Xu, et al.. (2020). SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity. Aging. 12(5). 4178–4192. 31 indexed citations
9.
10.
Geng, Yadi, Lei Zhang, Guoyu Wang, et al.. (2018). Xanthatin mediates G2/M cell cycle arrest, autophagy and apoptosis via ROS/XIAP signaling in human colon cancer cells. Natural Product Research. 34(18). 2616–2620. 19 indexed citations
11.
Geng, Yadi, Chao Zhang, Pei Yu, et al.. (2017). Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer. Biochemical Pharmacology. 142. 71–86. 23 indexed citations
12.
Zhang, Chao, Zunfeng Liu, Ying Zheng, et al.. (2017). Glycyrrhetinic Acid Functionalized Graphene Oxide for Mitochondria Targeting and Cancer Treatment In Vivo. Small. 14(4). 105 indexed citations
13.
Guo, Chao, Lei Yang, Chuanxing Wan, et al.. (2016). Anti-neuroinflammatory effect of Sophoraflavanone G from Sophora alopecuroides in LPS-activated BV2 microglia by MAPK, JAK/STAT and Nrf2/HO-1 signaling pathways. Phytomedicine. 23(13). 1629–1637. 107 indexed citations
14.
Zhang, Chao, Lei Yang, Yadi Geng, et al.. (2016). Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells. Oncotarget. 7(19). 27819–27837. 17 indexed citations
15.
Geng, Yadi, Chao Zhang, Yamin Shi, et al.. (2015). Icariside II-induced mitochondrion and lysosome mediated apoptosis is counterbalanced by an autophagic salvage response in hepatoblastoma. Cancer Letters. 366(1). 19–31. 31 indexed citations
16.
Shi, Yamin, Lei Yang, Yadi Geng, Chao Zhang, & Ling‐Yi Kong. (2015). Polyphyllin I induced-apoptosis is enhanced by inhibition of autophagy in human hepatocellular carcinoma cells. Phytomedicine. 22(13). 1139–1149. 59 indexed citations
17.
Xia, Yuan‐Zheng, Kai Ni, Chao Guo, et al.. (2015). Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling. Phytomedicine. 22(3). 344–351. 27 indexed citations
18.
Xia, Yuan‐Zheng, Lei Yang, Zhendong Wang, et al.. (2015). Schisandrin A enhances the cytotoxicity of doxorubicin by the inhibition of nuclear factor-kappa B signaling in a doxorubicin-resistant human osteosarcoma cell line. RSC Advances. 5(18). 13972–13984. 22 indexed citations
19.
Geng, Yadi, Lei Yang, Chao Zhang, & Ling‐Yi Kong. (2014). Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells. Food and Chemical Toxicology. 73. 7–16. 36 indexed citations
20.
Zhang, Chao, Lei Yang, Xiaobing Wang, et al.. (2013). Calyxin Y induces hydrogen peroxide-dependent autophagy and apoptosis via JNK activation in human non-small cell lung cancer NCI-H460 cells. Cancer Letters. 340(1). 51–62. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuhui Tong Breakdown of academic impact, for papers by Mohammad Jalili‐Nik Breakdown of academic impact, for papers by Ying Hou Breakdown of academic impact, for papers by Shulong Jiang Breakdown of academic impact, for papers by Saiprasad Gowrikumar Breakdown of academic impact, for papers by Yuan Gu Breakdown of academic impact, for papers by Nina Xue Breakdown of academic impact, for papers by Anqi Zeng Breakdown of academic impact, for papers by Jialin Sun
Rankless by CCL
2026